Potential of the domestic biosimile omalizumab in achievement of control in patients with severe asthma: short communication - PDF (Russian)


Copyright © Pharmarus Print Media, 2024

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies